Loading...
skip to Main Content

The #LiverCancerAwarenessMonth campaign on Twitter is on 🔥🔥🔥:

✳️ Impressions: 27.9 millions
✳️ Tweets: 6.097
✳️ Participants: 1.521

📢 There's still one week left, help us spread the word!

#LiverTwitter

@josewillemse on patients needs and wishes ✅ emphasizing on the much needed input by patients ✅ @ERN_RARE_LIVER is all about patients ✅ what patients need! @my_ueg @EASLnews #easlschool @ThomasBerg24 @dufour_jf @phil_newsome7 @UKEHamburg

Available now

Obesity and fatty liver disease

This episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the virus on patients with obesity and fatty liver disease. The panel of experts comprises Professor Sven Francque, Professor Nalu Navarro-Alvarez, Professor Luca Busetto and Professor Carolyn Bramante.

Viral hepatitis elimination

This latest episode of EASL’s webcast series on COVID-19 and the liver examines the impact of the pandemic on European efforts to eliminate hepatitis as a public health threat by 2030. Professor Antonio Craxi was joined by Professor Mark Thursz, Professor Jeffrey Lazarus, Dr Loreta Kondili and Sarah Blach for this important topic.

Cirrhosis, liver cancer and transplantation

As part of EASL’s continuing series on COVID-19 and the liver, Professor Agustin Albillos, Dr Gwilym Webb and Dr Massimo Iavarone come together for a three-part discussion on COVID-19, cirrhosis, liver cancer and transplantation.

Diagnostics of SARS-CoV-2

In this webcast, three world-renowned experts, Professor Jean-Michel Pawlotsky, Professor Jon Deeks and Professor Mario Mondelli, discuss the current state of COVID-19 diagnostics, evaluating how current diagnostic capabilities can best be used to establish risk, identify disease in individuals and to track the spread of SARS-CoV-2 within the population.

Update on the molecular virology and pathogenesis of SARS-CoV-2 and COVID-19

In the rapidly developing field of COVID-19 virology, Professor Darius Moradpour hosts this update to our current understanding of SARS-CoV-2 infection, supported by three world-renowned experts looking at the major challenges that lie ahead.

The #LiverCancerAwarenessMonth campaign on Twitter is on 🔥🔥🔥:

✳️ Impressions: 27.9 millions
✳️ Tweets: 6.097
✳️ Participants: 1.521

📢 There's still one week left, help us spread the word!

#LiverTwitter

@josewillemse on patients needs and wishes ✅ emphasizing on the much needed input by patients ✅ @ERN_RARE_LIVER is all about patients ✅ what patients need! @my_ueg @EASLnews #easlschool @ThomasBerg24 @dufour_jf @phil_newsome7 @UKEHamburg

Back To Top